Literature DB >> 9134272

Coronary risk factors, endothelial function, and atherosclerosis: a review.

R A Vogel1.   

Abstract

The traditional risk factors for coronary heart disease, which include hypercholesterolemia, hypertension, cigarette smoking, diabetes mellitus, and high-fat diet, have all been associated with impairments in endothelial function. Impaired endothelium function may promote the development of atherosclerosis through its effects on vasoregulation, platelet and monocyte adhesion, vascular smooth muscle cell growth, and coagulation. Increased oxidative stress may be another mechanism by which endothelial dysfunction contributes to atherosclerosis, although controversy exists on this issue. Risk factor modification, particularly lowering elevated concentrations of low-density lipoprotein cholesterol, improves endothelial function. At least seven clinical studies have demonstrated improved endothelial function with cholesterol reductions in patients with markedly elevated or even borderline elevations in cholesterol concentrations, whether or not coronary heart disease is present. Other interventions that improve endothelial function include blood pressure reduction, smoking cessation, and administration of estrogen to postmenopausal women.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9134272      PMCID: PMC6656192          DOI: 10.1002/clc.4960200505

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   2.882


  35 in total

1.  Effect of cholesterol lowering treatment on positive exercise tests in patients with hypercholesterolaemia and normal coronary angiograms.

Authors:  A P Mansur; C V Serrano; J C Nicolau; L A César; J A Ramires
Journal:  Heart       Date:  1999-12       Impact factor: 5.994

Review 2.  Assessing endothelial function as a risk factor for cardiovascular disease.

Authors:  Alan L Hinderliter; Melissa Caughey
Journal:  Curr Atheroscler Rep       Date:  2003-11       Impact factor: 5.113

Review 3.  Biomimetic nanoparticle technology for cardiovascular disease detection and treatment.

Authors:  Joon Ho Park; Diana Dehaini; Jiarong Zhou; Maya Holay; Ronnie H Fang; Liangfang Zhang
Journal:  Nanoscale Horiz       Date:  2019-06-28       Impact factor: 10.989

4.  Unraveling mechanisms of toxicant-induced oxidative stress in cardiovascular disease.

Authors:  Tammy R Dugas
Journal:  Curr Opin Toxicol       Date:  2017-10-12

Review 5.  HMG-CoA reductase inhibitors and myotoxicity.

Authors:  M Ucar; T Mjörndal; R Dahlqvist
Journal:  Drug Saf       Date:  2000-06       Impact factor: 5.606

6.  High prevalence of subclinical atherosclerosis in Brazilian postmenopausal women with low and intermediate risk by Framingham score.

Authors:  Ana Claudia Gomes Pereira Petisco; Jorge Eduardo Assef; Carlos Alberto de Jesus; Mohamed Hassan Saleh; Jose Eduardo Martins Barbosa; David Costa de Souza Le Bihan; Ibraim Masciarelli França Pinto; Simone Rolim Fernandes Fontes Pedra; Rodrigo Bellio de Mattos Barretto; Amanda Guerra de Moraes Rego Sousa
Journal:  Int J Cardiovasc Imaging       Date:  2016-10-20       Impact factor: 2.357

7.  Reducing Cardiovascular Disease Risk in Women Beyond Statin Therapy: New Insights 2020.

Authors:  Lori Mosca; Ann Marie Navar; Nanette Kass Wenger
Journal:  J Womens Health (Larchmt)       Date:  2020-04-13       Impact factor: 2.681

Review 8.  Oxidative stress as a mechanism of added sugar-induced cardiovascular disease.

Authors:  Kailash Prasad; Indu Dhar
Journal:  Int J Angiol       Date:  2014-12

Review 9.  Effects of HMG-CoA reductase inhibitors on skeletal muscle: are all statins the same?

Authors:  Marc Evans; Alan Rees
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

10.  Effect of Shengmai injection on vascular endothelial and heart functions in patients with coronary heart disease complicated with diabetes mellitus.

Authors:  Ya-chen ZHANG; Bao-jing LU; Mei-hua ZHAO; Ye-zhi RONG; Rui-ming CHEN
Journal:  Chin J Integr Med       Date:  2008-12-12       Impact factor: 1.978

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.